US5514720A
(en)
*
|
1986-07-09 |
1996-05-07 |
Hemagen/Pfc |
Stable emulsions of highly fluorinated organic compounds
|
US5684050A
(en)
*
|
1986-01-24 |
1997-11-04 |
Hemagen/Pfc |
Stable emulsions of highly fluorinated organic compounds
|
DE68928349T2
(de)
*
|
1989-07-05 |
1998-05-07 |
Alliance Pharma |
Fluorkohlenstoffemulsionen mit gesättigten phospholipidemulgatoren
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5922304A
(en)
*
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
IN172208B
(de)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
US6274148B1
(en)
*
|
1990-11-08 |
2001-08-14 |
Chiron Corporation |
Hepatitis C virus asialoglycoproteins
|
US5205290A
(en)
*
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
FR2679150A1
(fr)
*
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
RU2114637C1
(ru)
*
|
1991-09-17 |
1998-07-10 |
Сонус Фармасьютикалз, Инк. |
Биосовместимая контрастная среда и способ получения ультразвукового изображения
|
MX9205298A
(es)
*
|
1991-09-17 |
1993-05-01 |
Steven Carl Quay |
Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
|
US6875420B1
(en)
|
1991-09-17 |
2005-04-05 |
Amersham Health As |
Method of ultrasound imaging
|
US5409688A
(en)
*
|
1991-09-17 |
1995-04-25 |
Sonus Pharmaceuticals, Inc. |
Gaseous ultrasound contrast media
|
US6723303B1
(en)
|
1991-09-17 |
2004-04-20 |
Amersham Health, As |
Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
|
US5304325A
(en)
*
|
1991-11-13 |
1994-04-19 |
Hemagen/Pfc |
Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
|
US5403575A
(en)
*
|
1991-12-12 |
1995-04-04 |
Hemagen/Pfc |
Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
|
US5295953A
(en)
*
|
1992-05-26 |
1994-03-22 |
Hemagen/Pfc |
Method and apparatus for extracorporeal separation of fluorochemicals from whole blood of a patient
|
US5628930A
(en)
*
|
1992-10-27 |
1997-05-13 |
Alliance Pharmaceutical Corp. |
Stabilization of fluorocarbon emulsions
|
US5420359A
(en)
*
|
1992-12-11 |
1995-05-30 |
Minnesota Mining And Manufacturing Company |
Chlorofluoroether compositions and preparation thereof
|
WO1994014415A1
(en)
*
|
1992-12-24 |
1994-07-07 |
Hemagen/Pfc |
Fluorocarbon emulsions
|
US5558855A
(en)
*
|
1993-01-25 |
1996-09-24 |
Sonus Pharmaceuticals |
Phase shift colloids as ultrasound contrast agents
|
ATE200985T1
(de)
*
|
1993-01-25 |
2001-05-15 |
Sonus Pharma Inc |
Phase-stift kolloide zur verwendung als ultraschallkontrastmittel
|
IL108416A
(en)
|
1993-01-25 |
1998-10-30 |
Sonus Pharma Inc |
Colloids with phase difference as contrast ultrasound agents
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
US5362478A
(en)
*
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
US5525324A
(en)
*
|
1993-08-06 |
1996-06-11 |
Block; Ronald E. |
Organic silicon contrast agents and methods of use
|
AU679295B2
(en)
|
1993-12-15 |
1997-06-26 |
Bracco Suisse S.A. |
Gas mixtures useful as ultrasound contrast media
|
US5502094A
(en)
*
|
1994-05-20 |
1996-03-26 |
Minnesota Mining And Manufacturing Company |
Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
|
US5658962A
(en)
|
1994-05-20 |
1997-08-19 |
Minnesota Mining And Manufacturing Company |
Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
CA2152765A1
(en)
|
1994-06-30 |
1995-12-31 |
Jeroen Elisabeth-Joseph Knops |
Methods for treating a physiological disorder associated with beta amyloid peptide
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US5804162A
(en)
*
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
DE19529921C2
(de)
*
|
1995-08-01 |
1997-09-25 |
Schering Ag |
Verwendung von MRT-Kontrastmitteln zur Ventilations-Bildgebung der Lunge
|
EP0862434A1
(de)
*
|
1995-10-25 |
1998-09-09 |
Janssen Pharmaceutica N.V. |
Neuroschützende mittel und perfluorverbindungen enthaltende infusionen
|
US5733526A
(en)
*
|
1995-12-14 |
1998-03-31 |
Alliance Pharmaceutical Corp. |
Hydrocarbon oil/fluorochemical preparations and methods of use
|
WO1997025978A1
(fr)
*
|
1996-01-15 |
1997-07-24 |
BELOYARTSEV, Arkady Felixovich |
Procede de production d'emulsions perfluorocarbonees a des fins medicales
|
ATE266426T1
(de)
*
|
1996-03-05 |
2004-05-15 |
Acusphere Inc |
Mikroverkapselte fluorierte gase zur anwendung als bilderzeugende mittel
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
CA2252617A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
DK0977597T3
(da)
|
1996-09-11 |
2003-05-05 |
Imarx Pharmaceutical Corp |
Forbedrede fremgangsmåder til diagnostisk billeddannelse ved hjælp af et kontrastmiddel og en vasodilatator.
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
EP1001816A4
(de)
*
|
1996-11-25 |
2002-07-17 |
Imarx Pharmaceutical Corp |
Perfluoriete ethern zusammensetzungen wie kontrastmittel
|
DE19701037A1
(de)
*
|
1997-01-15 |
1998-07-16 |
Sanguibiotech Ag |
Mit Schutzliganden der Sauerstoffbindungsstellen versehene Hämoglobine als künstliche Sauerstoffträger zur direkten biologisch-medizinischen Anwendung und Verfahren zu ihrer Herstellung
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6537246B1
(en)
*
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
JPH113349A
(ja)
*
|
1997-06-11 |
1999-01-06 |
Fujitsu Ltd |
データ保護システム,データ作成装置及びデータ加工装置
|
US5980936A
(en)
*
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US7220401B2
(en)
*
|
1999-09-24 |
2007-05-22 |
Barnes-Jewish Hospital |
Blood clot-targeted nanoparticles
|
BR0100091A
(pt)
|
2000-01-18 |
2001-08-28 |
Implant Innovations Inc |
Cobertura de preparação para criar um pino permanente preciso para suportar uma prótese final e método para a criação da mesma
|
KR100372555B1
(ko)
*
|
2000-04-20 |
2003-02-17 |
주식회사 도도화장품 |
산소를 용해시킨 과플루오로데칼린과 대두에서 추출한유용성분을 함유하는 미백용 화장품의 제조방법
|
US6676963B1
(en)
*
|
2000-10-27 |
2004-01-13 |
Barnes-Jewish Hospital |
Ligand-targeted emulsions carrying bioactive agents
|
EP1572639A4
(de)
|
2002-01-24 |
2006-08-09 |
Barnes Jewish Hospital |
Auf integrin zielende mittel zur bilddarstellung
|
EP1365068B1
(de)
*
|
2002-05-10 |
2008-05-07 |
The Procter & Gamble Company |
Geprägtes Tissue mit abstehenden Oberflächenfasern und Verfahren zu dessen Herstellung
|
RU2259819C1
(ru)
*
|
2004-03-01 |
2005-09-10 |
Кузнецова Ирина Николаевна |
Эмульсия перфторорганических соединений медицинского назначения и способ её получения
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
US7504088B2
(en)
|
2004-06-09 |
2009-03-17 |
Kereos, Inc. |
Lipophilic derivatives of chelate monoamides
|
US20070258908A1
(en)
*
|
2006-04-27 |
2007-11-08 |
Lanza Gregory M |
Detection and imaging of target tissue
|
DE602007003135D1
(de)
|
2006-05-18 |
2009-12-24 |
Mitsubishi Gas Chemical Co |
Verfahren zur Herstellung von Xylylenediamin
|
DE102006040450B3
(de)
*
|
2006-08-24 |
2008-04-24 |
Coty Prestige Lancaster Group Gmbh |
Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung
|
US9468607B2
(en)
|
2007-10-09 |
2016-10-18 |
Washington University |
Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
|
EP2209420A4
(de)
|
2007-10-09 |
2014-01-22 |
Univ St Louis |
Partikel für bildgebung
|
US9764043B2
(en)
|
2009-12-17 |
2017-09-19 |
Washington University |
Antithrombotic nanoparticle
|
US9808500B2
(en)
|
2009-12-17 |
2017-11-07 |
Washington University |
Antithrombotic nanoparticle
|
US9498439B2
(en)
|
2010-04-15 |
2016-11-22 |
Washington University |
Prodrug compositions, prodrug nanoparticles, and methods of use thereof
|
FR2980364B1
(fr)
|
2011-09-26 |
2018-08-31 |
Guerbet |
Nanoemulsions et leur utilisation comme agents de contraste
|
FR2980365B1
(fr)
|
2011-09-26 |
2016-02-12 |
Guerbet Sa |
Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste.
|
US9095521B2
(en)
|
2012-02-02 |
2015-08-04 |
Washington University |
Methods for improving muscle strength
|
EP2783703A1
(de)
*
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semi-Fluorkohlenstoff-Verbindung mit Kontrastmittel
|
RU2544849C1
(ru)
*
|
2014-01-09 |
2015-03-20 |
Общество с ограниченной ответственностью "Химический завод фторсолей" |
Способ очистки перфтордекалина
|
CN107206111B
(zh)
|
2014-12-31 |
2021-04-27 |
蓝瑟斯医学影像公司 |
脂质封装的气体微球组合物及相关方法
|
CN105248412A
(zh)
*
|
2015-10-30 |
2016-01-20 |
暨南大学 |
一种乳化氟碳液在制备肺器官保存液中的应用
|
US10213448B2
(en)
|
2016-03-25 |
2019-02-26 |
Novazoi Theranostics |
Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof
|
AU2017260532A1
(en)
|
2016-05-04 |
2018-11-22 |
Lantheus Medical Imaging, Inc. |
Methods and devices for preparation of ultrasound contrast agents
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
CN108849861A
(zh)
*
|
2018-09-30 |
2018-11-23 |
南京麦荻泉生物科技有限公司 |
一种含有氟碳乳剂型器官保存液
|
WO2024046999A1
(de)
*
|
2022-08-31 |
2024-03-07 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Lecithin-modifizierte nanoskalierte sauerstoffträger (lenox)
|